Galmed Pharma (GLMD) Misses Q1 EPS by 3c
Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.36), $0.03 worse than the analyst estimate of ($0.33).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.
Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.36), $0.03 worse than the analyst estimate of ($0.33).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.